ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53
Authors:
Open Access
- 7 May 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (11) , 5295-5304
Abstract
Acute myeloid leukaemia is a complex, highly aggressive hematopoietic disorder. Currently, in spite of great advances in radiotherapy and chemotherapy, the prognosis for AML patients with initial treatment failure is still poor. Therefore, the need for novel and efficient therapies to improve AML treatment outcome has become desperately urgent. In this study, we identified the expression of ZEB1 (a transcription factor) and focused on its possible role and mechanisms in the progression of AML. According to the data provided by the Gene Expression Profiling Interactive Analysis (GEPIA), high expression of ZEB1 closely correlates with poor prognosis in AML patients. Additionally, the overexpression of ZEB1 was observed in both AML patients and cell lines. Further functional experiments showed that ZEB1 depletion can induce AML differentiation and inhibit AML proliferation in vitro and in vivo. Moreover, ZEB1 expression was negatively correlated with tumour suppressor P53 expression and ZEB1 can directly bind to P53. Our results also revealed that ZEB1 can regulate PTEN/PI3K/AKT signalling pathway. The inhibitory effect of ZEB1 silencing on PTEN/PI3K/AKT signalling pathway could be significantly reversed by P53 small interfering RNA treatment. Overall, the present data indicated that ZEB1 may be a promising therapeutic target for AML treatment or a potential biomarker for diagnosis and prognosis.Keywords
This publication has 46 references indexed in Scilit:
- Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid LeukemiaPLOS Genetics, 2012
- Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marksBlood, 2011
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011
- Quantitative DNA methylation predicts survival in adult acute myeloid leukemiaBlood, 2010
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAsNature Cell Biology, 2009
- δEF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineageJournal of Biomedical Science, 2007
- Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 resultsLeukemia, 2005
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Plasma Levels of Somatostatin and Gastrin in Sick Infants and Small for Gestational Age InfantsJournal of Pediatric Gastroenterology and Nutrition, 1988
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979